KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Other Accumulated Expenses (2020 - 2025)

Gilead Sciences' Other Accumulated Expenses history spans 11 years, with the latest figure at $4.0 billion for Q4 2025.

  • For Q4 2025, Other Accumulated Expenses fell 27.65% year-over-year to $4.0 billion; the TTM value through Dec 2025 reached $4.0 billion, down 27.65%, while the annual FY2025 figure was $4.0 billion, 27.65% down from the prior year.
  • Other Accumulated Expenses reached $4.0 billion in Q4 2025 per GILD's latest filing, up from $3.8 billion in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $6.1 billion in Q4 2021 to a low of $3.6 billion in Q2 2025.
  • Average Other Accumulated Expenses over 5 years is $4.8 billion, with a median of $4.6 billion recorded in 2022.
  • Peak YoY movement for Other Accumulated Expenses: surged 168.69% in 2021, then dropped 27.65% in 2025.
  • A 5-year view of Other Accumulated Expenses shows it stood at $6.1 billion in 2021, then fell by 25.47% to $4.6 billion in 2022, then increased by 12.01% to $5.1 billion in 2023, then grew by 6.51% to $5.5 billion in 2024, then dropped by 27.65% to $4.0 billion in 2025.
  • Per Business Quant, the three most recent readings for GILD's Other Accumulated Expenses are $4.0 billion (Q4 2025), $3.8 billion (Q3 2025), and $3.6 billion (Q2 2025).